Kader Chouahnia

Bobigny, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Cryoablation as a downsizing strategy enabling R0 resection in a giant mediastinal desmoid tumor: a case report.

Cryoablation as a downsizing strategy enabling R0 resection in a giant mediastinal desmoid tumor: a case report.

Journal: Mediastinum (Hong Kong, China)
Published: January 15, 2026

Brief Report: Real-World Comparative Effectiveness of First-Line Immune Checkpoint Inhibitor Monotherapy Versus Chemo-Immunotherapy in Metastatic NSCLC With PD-L1 More Than or Equal to 50%: A Meta-Analysis.

Brief Report: Real-World Comparative Effectiveness of First-Line Immune Checkpoint Inhibitor Monotherapy Versus Chemo-Immunotherapy in Metastatic NSCLC With PD-L1 More Than or Equal to 50%: A Meta-Analysis.

Journal: JTO clinical and research reports
Published: December 12, 2025

Tracheobronchial Replacement Using Cryopreserved Aortic Allografts: Results in 50 Patients (TRITON-01 Registry).

Tracheobronchial Replacement Using Cryopreserved Aortic Allografts: Results in 50 Patients (TRITON-01 Registry).

Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Published: August 26, 2025

Tracheobronchial Replacement: A Systematic Review.

Tracheobronchial Replacement: A Systematic Review.

Journal: JAMA surgery
Published: May 28, 2025

First-line concomitant EGFR-TKI + chemotherapy versus EGFR-TKI alone for advanced EGFR-mutated NSCLC: a meta-analysis of randomized phase III trials.

First-line concomitant EGFR-TKI + chemotherapy versus EGFR-TKI alone for advanced EGFR-mutated NSCLC: a meta-analysis of randomized phase III trials.

Journal: Expert review of anticancer therapy
Published: May 30, 2024

Total Metabolic Tumor Volume on 18F-FDG PET/CT Is a Useful Prognostic Biomarker for Patients with Extensive Small-Cell Lung Cancer Undergoing First-Line Chemo-Immunotherapy.

Total Metabolic Tumor Volume on 18F-FDG PET/CT Is a Useful Prognostic Biomarker for Patients with Extensive Small-Cell Lung Cancer Undergoing First-Line Chemo-Immunotherapy.

Journal: Cancers
Published: March 02, 2023

Preliminary results in tracheal replacement using stented aortic matrices for primary extensive tracheal cancer.

Preliminary results in tracheal replacement using stented aortic matrices for primary extensive tracheal cancer.

Journal: JTCVS techniques
Published: February 28, 2023

Postoperative radiotherapy in non-small cell lung cancer stage IIIA - N2: Focus and perspectives

Postoperative radiotherapy in non-small cell lung cancer stage IIIA - N2: Focus and perspectives

Journal: Bulletin du cancer
Published: May 16, 2022

Successful sequential tyrosine kinase inhibitors to overcome a rare compound of EGFR exon 18-18 and EGFR amplification: A case report.

Successful sequential tyrosine kinase inhibitors to overcome a rare compound of EGFR exon 18-18 and EGFR amplification: A case report.

Journal: Frontiers in oncology
Published: April 12, 2022

Airway replacement using stented aortic matrices: Long-term follow-up and results of the TRITON-01 study in 35 adult patients.

Airway replacement using stented aortic matrices: Long-term follow-up and results of the TRITON-01 study in 35 adult patients.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: April 04, 2022

Adoptive cell therapies in thoracic malignancies.

Adoptive cell therapies in thoracic malignancies.

Journal: Cancer immunology, immunotherapy : CII
Published: September 04, 2021

Anti-PD-(L)1 for KRAS-mutant advanced non-small-cell lung cancers: a meta-analysis of randomized-controlled trials.

Anti-PD-(L)1 for KRAS-mutant advanced non-small-cell lung cancers: a meta-analysis of randomized-controlled trials.

Journal: Cancer immunology, immunotherapy : CII
Published: April 14, 2021
Showing 1-12 of 34

Last Updated: 09/26/2026